Table 1. Summary of evidence by cancer type.
Cancer Type | In Vitro | In Vivo | Case Report/Trial |
---|---|---|---|
Angiosarcoma | [43] | [43] | [44, 81, 82] NCT02732678 |
Breast | [24–31] | [79] NCT01847001, NCT02596867, NCT00502684 ACTRN12615000889550 |
|
Colorectal | [55, 57] | [58] |
NCT00888797 ACTRN12612000852853 |
Gastric | [66, 67] | ||
Glioblastoma | [83, 84] | ||
HCC | [86] NCT01265576 |
||
Leukaemia | [21, 60] | [22] | |
Melanoma | [34, 35] | [33, 36] | NCT01988831 |
Multiple myeloma | [70] | ||
Nasopharygeal | [59] | ||
Neuroblastoma | [45, 47] | [46, 47] |
NCT02641314 NCT02897986 |
NSCLC | [68] | ||
Oral SCC | [61, 62] | ||
Ovarian | [38] | [39, 40] | NCT01504126 |
Pancreatic | [50–52] | [53, 54] | [85] |
Prostate | [48] | NCT01857817 |